MONTANOVA CAPITAL, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001569064

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q2 2026 · 96 positions · Total reported value $5.47B · Top-10 concentration 49.1% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 47.3% · 21 new · 17 cut · 14 exited

Active Share (vs S&P 500): 88.7% · vs QQQ: 90.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +26.5% · vs SPY +11.7% · Prev Value $3.92B — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2026 13F filing, MONTANOVA CAPITAL, LLC disclosed 96 equity positions with a combined reported value of $5.47B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 49.1% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2026 were SPY ($709.43M), MANE ($512.53M), ARQT ($326.10M). By sector, the heaviest allocations are Health Care 50.9%, Technology 14.2%. Versus the prior quarter, allocation shifted toward Other (+3.2pp), Technology (+2.8pp) and away from Industrials (-0.6pp), Consumer Discretionary (-1.5pp).

Versus the prior quarter, MONTANOVA CAPITAL, LLC opened 21 new positions, trimmed 17 and fully exited 14, a turnover rate of 47.3% of positions. The portfolio's overlap with the prior quarter was 68% of names.

The largest new positions opened in Q2 2026 were AVLN ($82.40M), HUT ($77.35M), APH ($47.48M).

Of the 14 positions fully exited versus the prior quarter, the largest were APLS ($141.55M), KALV ($95.99M), ERAS ($55.58M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

  • AVLN AVALYN PHARMA INC · $82.40M
  • HUT HUT 8 CORP · $77.35M
  • APH AMPHENOL CORP · $47.48M
  • DRAM ROUNDHILL ETF TRUST · $44.53M
  • CBRS CEREBRAS SYSTEMS INC · $37.99M
  • DKS DICKS SPORTING GOODS INC · $34.32M
  • AVGO BROADCOM INC · $31.58M
  • SPCX SPACE EXPLORATION TECHN CORP · $17.29M

Fully Exited (vs previous quarter)

  • APLS APELLIS PHARMACEUTICALS INC · prev qtr: $141.55M
  • KALV KALVISTA PHARMACEUTICALS INC · prev qtr: $95.99M
  • ERAS ERASCA INC · prev qtr: $55.58M
  • LTH LIFE TIME GROUP HOLDINGS INC · prev qtr: $13.75M
  • WING WINGSTOP INC · prev qtr: $9.22M
  • COHR COHERENT CORP · prev qtr: $7.15M
  • MDT MEDTRONIC PLC · prev qtr: $6.26M
  • KZR KEZAR LIFE SCIENCES INC · prev qtr: $5.32M

Insider Transactions (Form 4)

Latest MONTANOVA CAPITAL, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-08-20 Opt exercise Veradermics, Inc 151,000 — SEC filing
2026-08-20 Opt exercise Veradermics, Inc 149,000 — SEC filing
2026-08-19 Sell Veradermics, Inc 59,399 $107.25 SEC filing
2026-08-19 Sell Veradermics, Inc 690,601 $107.25 SEC filing

All insider transactions →

Fund Profile

Montanova Capital, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 96 positions worth $5.47B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-79962 (status: Approved), registered 2014-06-26
  • Regulatory AUM (Form ADV): $7.87B as of 2026-07-01
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds, of which 3 hedge funds
  • Website: montanova.com

Portfolio Structure

  • 96 positions · $5.47B reported value (Q2 2026)
  • Top 10 holdings = 49.1% of reported value
  • Largest position: SPY (STATE STR SPDR S&P 500 ETF T) at 13.0%
  • Average position size: $56.96M

Sector Tilt

  • Health Care 50.9%
  • Information Technology 14.5%
  • Consumer Discretionary 8.3%
  • (classified holdings cover 83% of value)

Quarterly Activity

  • Q2 2026: 21 new, 26 added, 17 reduced, 14 exited
  • 32 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 50.9%
Technology 14.2%
Financials 4.3%
Other 17.0%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 950.00K $709.43M 12.97%
12.97%
Add
2 4.17M $512.53M 9.37%
9.37%
Hold
3 12.44M $326.10M 5.96%
5.96%
Add
4 7.07M $204.18M 3.73%
3.73%
Reduce
5 1.14M $173.51M 3.17%
3.17%
Reduce
6 4.52M $156.87M 2.87%
2.87%
Add
7 11.55M $154.52M 2.83%
2.83%
Hold
8 10.29M $153.07M 2.80%
2.80%
Hold
9 257.24K $149.43M 2.73%
2.73%
Hold
10 4.78M $147.26M 2.69%
2.69%
Reduce
11 304.63K $145.48M 2.66%
2.66%
Add
12 720.61K $144.19M 2.64%
2.64%
Add
13 8.30M $118.64M 2.17%
2.17%
Hold
14 1.41M $117.98M 2.16%
2.16%
Add
15 310.26K $115.95M 2.12%
2.12%
Hold
16 11.19M $113.36M 2.07%
2.07%
Hold
17 2.33M $111.18M 2.03%
2.03%
Add
18 175.81K $99.03M 1.81%
1.81%
Add
19 4.09M $98.55M 1.80%
1.80%
Add
20 8.58M $94.07M 1.72%
1.72%
Hold
21 3.55M $85.90M 1.57%
1.57%
Reduce
22 2.50M $82.40M 1.51%
1.51%
New
23 226.05K $79.72M 1.46%
1.46%
Add
24 670.00K $77.35M 1.42%
1.42%
New
25 333.10K $66.83M 1.22%
1.22%
Add
26 214.98K $63.42M 1.16%
1.16%
Add
27 246.76K $58.56M 1.07%
1.07%
Add
28 9.44M $55.71M 1.02%
1.02%
Add
29 22.93M $51.37M 0.94%
0.94%
Add
30 7.21M $51.16M 0.94%
0.94%
Add
31 2.02M $50.50M 0.92%
0.92%
Add
32 9.74M $49.47M 0.91%
0.91%
Add
33 204.86K $48.83M 0.89%
0.89%
Reduce
34 4.39M $48.60M 0.89%
0.89%
Add
35 269.30K $47.48M 0.87%
0.87%
New
36 101.80K $46.74M 0.85%
0.85%
Add
37 2.84M $46.57M 0.85%
0.85%
Hold
38 383.30K $45.35M 0.83%
0.83%
Reduce
39 789.72K $45.00M 0.82%
0.82%
Reduce
40 603.00K $44.53M 0.81%
0.81%
New
41 1.19M $44.39M 0.81%
0.81%
Add
42 171.90K $37.99M 0.69%
0.69%
New
43 151.32K $34.32M 0.63%
0.63%
New
44 83.60K $31.58M 0.58%
0.58%
New
45 14.10M $30.88M 0.56%
0.56%
Reduce
46 6.38M $29.72M 0.54%
0.54%
Add
47 64.13K $26.65M 0.49%
0.49%
Reduce
48 12.34M $25.18M 0.46%
0.46%
Hold
49 4.30M $19.69M 0.36%
0.36%
Add
50 101.20K $17.29M 0.32%
0.32%
New

FAQ

What did MONTANOVA CAPITAL, LLC buy in 2026-Q2?

In its 2026-Q2 13F filing, MONTANOVA CAPITAL, LLC reported 96 equity positions worth $5.47B in aggregate; its largest disclosed positions were SPY ($709.43M), MANE ($512.53M), ARQT ($326.10M).

How large is MONTANOVA CAPITAL, LLC's portfolio?

MONTANOVA CAPITAL, LLC reported $5.47B of long equity holdings across 96 positions as of 2026-Q2. Top-10 holdings account for 49.1% of reported value.

What is MONTANOVA CAPITAL, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/montanova-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →